Robust data sets which can effectively represent diverse populations are key to driving greater inclusivity in trials.
Jen Lamppa
Advertisement
Associate Vice President, Clinical Analytics, Inovalon
Articles by Jen Lamppa
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
3
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
4
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
